| License: Creative Commons Attribution 4.0 (237kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-380727
- DOI to cite this document:
- 10.5283/epub.38072
Abstract
Gliomas are highly invasive brain tumors with short patient survival. One major pathogenic factor is aberrant tumor metabolism, which may be targeted with different specific and unspecific agents. Drug repurposing is of increasing interest in glioma research. Drugs interfering with the patient’s metabolism may also influence glioma metabolism. In this review, we outline definitions and methods ...
Owner only: item control page
Download Statistics